Sexually Transmitted Diseases (STDs)

Health Care Provider Alert: Sexually Transmitted Hepatitis A among Men who have Sex with Men (MSM)

On March 20, 2017, NYSDOH Commissioner Howard Zucker issued a letter describing an increase in Hepatitis A cases among MSM in New York City and other metropolitan counties. The full advisory is available at the NYS Health Commerce System (restricted access; account required).

Vaccination and screening recommendations for this population are available at www.cdc.gov. Providers should consider offering vaccination for both Hepatitis A and Hepatitis B, if patients are not already immune. Uninsured patients can also call their local health department to see if they are eligible for free or low-cost vaccination.

For more information about Hepatitis A and the Hepatitis A vaccine, visit:

 

Health Advisory Update: Continued Shortage of Bicillin L-A® and Procaine Penicillin G

Pfizer, the manufacturer of Bicillin L-A® (penicillin G benzathine) and Penicillin G procaine, has indicated that the shortages of these products is likely to continue until late 2017.  There are currently no changes to CDC’s recommended treatments for syphilis (Bicillin L-A®), congenital syphilis, ocular syphilis or neurosyphilis (Penicillin G procaine). 

Providers are encouraged to prioritize use of Bicillin L-A® for pregnant women exposed to or infected with syphilis, as there are no alternate treatments.

In the absence of Penicillin G procaine, providers should consider using other alternate, recommended treatment therapies for congenital syphilis, as listed in the CDC 2015 STD Treatment Guidelines.  Penicillin G procaine is an alternate treatment option for ocular syphilis and neurosyphilis. Providers should use the preferred treatment, or another alternate treatment when the preferred treatment is not feasible.

For more information on the status of these shortages, visit the FDA Drug Shortages database and search “Penicillin”. More information on treatment recommendations for congenital syphilis, ocular and neurosyphilis are available in the CDC 2015 STD Treatment Guidelines.